The man's murder case was not pursued in court after experts determined he was suffering from Huntington's Disease.

What happens when 250 fine wines, great food, and a powerful cause come together? Discover how Corks & Forks is bringing hope to those fighting Huntington's disease. Read the full article at Corks & F ...

CLEVELAND, Ohio — Whole brain radiotherapy saves lives by treating cancer that has spread to the brain, but it also causes long-standing brain damage. Many patients who go through whole brain ...

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary endpoint, showing clinically ...

Greetings from Day 2 of the CHDI HD Therapeutics Conference! HDBuzz continues to provide summaries of the exciting talks from HD scientists gathered in Palm Springs from around the world. This day’s ...

Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...